The Bioweapon Governance Gap: Synthetic Biology Is Outpacing the Treaties Designed to Contain It
Problem Definition
The Biological Weapons Convention (BWC), signed in 1972, prohibits bioweapon development but has no verification mechanism, no inspection regime, and no enforcement body — making it the weakest arms control treaty of the major weapons categories.
Meanwhile, the tools of synthetic biology are becoming exponentially cheaper and more accessible, moving bioweapon capability from nation-states to small groups. The combination of AI-assisted pathogen design, cheap DNA synthesis, and widely available biological knowledge creates a threat landscape that existing governance was not designed to address.
A single engineered pandemic could kill millions — and the warning time between capability acquisition and deployment may be days.
Root Causes
BWC lacks verification mechanism — no inspections, no compliance monitoring, no enforcement
Dual-use nature of biology makes it impossible to separate legitimate research from weapons-relevant work at the technical level
Gene synthesis industry is globally fragmented with inconsistent screening for dangerous sequences
AI tools for protein design and pathogen modification are openly published and globally accessible
Biosecurity funding is a fraction of cybersecurity and nuclear security investment despite comparable or greater risk